Seungmin Lee , Han-Joon Kim , Seoyeon Kim , Bora Jin , HoYoung Jeon , Kyung Ah Woo , Jung Hwan Shin , Chansub Lee , Choonghyun Sun , Hogune Im , Hongyul An , Young Il Koh , Su-Yeon Choi , Beomseok Jeon
{"title":"DNMT3A 突变导致的克隆性造血与多系统萎缩有关","authors":"Seungmin Lee , Han-Joon Kim , Seoyeon Kim , Bora Jin , HoYoung Jeon , Kyung Ah Woo , Jung Hwan Shin , Chansub Lee , Choonghyun Sun , Hogune Im , Hongyul An , Young Il Koh , Su-Yeon Choi , Beomseok Jeon","doi":"10.1016/j.parkreldis.2024.107145","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Clonal hematopoiesis of indeterminate potential (CHIP) is associated with cardiovascular diseases and other disorders, possibly via inflammation. Recent research suggests a connection of CHIP with neurodegenerative disorders.</p></div><div><h3>Objective</h3><p>We aimed to investigate the association between multiple system atrophy (MSA) and CHIP.</p></div><div><h3>Methods</h3><p>We included 100 patients with MSA and 4457 controls. Targeted sequencing of peripheral blood DNA samples was performed, focusing on a panel of 25 genes commonly.</p></div><div><h3>Linked to chip</h3><p>The prevalence of CHIP in patients with MSA was assessed against controls at variant allele frequency (VAF) thresholds of 1.5 % and 2.0 %.</p></div><div><h3>Results</h3><p>DNMT3A mutation rates were significantly higher in patients with MSA, with a VAF of 1.5 %, which remained significant after adjusting for age and sex (adjusted odds ratio, 1.848; 95 % CI, 1.024–3.335; p = 0.0416).</p></div><div><h3>Conclusion</h3><p>Our results suggest an association between DNMT3A mutations and MSA.</p></div>","PeriodicalId":19970,"journal":{"name":"Parkinsonism & related disorders","volume":"128 ","pages":"Article 107145"},"PeriodicalIF":3.1000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clonal hematopoiesis with DNMT3A mutations is associated with multiple system atrophy\",\"authors\":\"Seungmin Lee , Han-Joon Kim , Seoyeon Kim , Bora Jin , HoYoung Jeon , Kyung Ah Woo , Jung Hwan Shin , Chansub Lee , Choonghyun Sun , Hogune Im , Hongyul An , Young Il Koh , Su-Yeon Choi , Beomseok Jeon\",\"doi\":\"10.1016/j.parkreldis.2024.107145\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Clonal hematopoiesis of indeterminate potential (CHIP) is associated with cardiovascular diseases and other disorders, possibly via inflammation. Recent research suggests a connection of CHIP with neurodegenerative disorders.</p></div><div><h3>Objective</h3><p>We aimed to investigate the association between multiple system atrophy (MSA) and CHIP.</p></div><div><h3>Methods</h3><p>We included 100 patients with MSA and 4457 controls. Targeted sequencing of peripheral blood DNA samples was performed, focusing on a panel of 25 genes commonly.</p></div><div><h3>Linked to chip</h3><p>The prevalence of CHIP in patients with MSA was assessed against controls at variant allele frequency (VAF) thresholds of 1.5 % and 2.0 %.</p></div><div><h3>Results</h3><p>DNMT3A mutation rates were significantly higher in patients with MSA, with a VAF of 1.5 %, which remained significant after adjusting for age and sex (adjusted odds ratio, 1.848; 95 % CI, 1.024–3.335; p = 0.0416).</p></div><div><h3>Conclusion</h3><p>Our results suggest an association between DNMT3A mutations and MSA.</p></div>\",\"PeriodicalId\":19970,\"journal\":{\"name\":\"Parkinsonism & related disorders\",\"volume\":\"128 \",\"pages\":\"Article 107145\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Parkinsonism & related disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S135380202401157X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinsonism & related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S135380202401157X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Clonal hematopoiesis with DNMT3A mutations is associated with multiple system atrophy
Background
Clonal hematopoiesis of indeterminate potential (CHIP) is associated with cardiovascular diseases and other disorders, possibly via inflammation. Recent research suggests a connection of CHIP with neurodegenerative disorders.
Objective
We aimed to investigate the association between multiple system atrophy (MSA) and CHIP.
Methods
We included 100 patients with MSA and 4457 controls. Targeted sequencing of peripheral blood DNA samples was performed, focusing on a panel of 25 genes commonly.
Linked to chip
The prevalence of CHIP in patients with MSA was assessed against controls at variant allele frequency (VAF) thresholds of 1.5 % and 2.0 %.
Results
DNMT3A mutation rates were significantly higher in patients with MSA, with a VAF of 1.5 %, which remained significant after adjusting for age and sex (adjusted odds ratio, 1.848; 95 % CI, 1.024–3.335; p = 0.0416).
Conclusion
Our results suggest an association between DNMT3A mutations and MSA.
期刊介绍:
Parkinsonism & Related Disorders publishes the results of basic and clinical research contributing to the understanding, diagnosis and treatment of all neurodegenerative syndromes in which Parkinsonism, Essential Tremor or related movement disorders may be a feature. Regular features will include: Review Articles, Point of View articles, Full-length Articles, Short Communications, Case Reports and Letter to the Editor.